The influence of androgen deprivation therapy (ADT) on 11C-choline uptake in patients with recurrent prostate cancer (PC) has not yet been clarified and there are no recommendations in the literature about the question of whether ADT should be discontinued before 11C-choline PET/CT The aim of our study was to investigate this issue by means of sequential 11Ccholine positron emission tomography (PET)/CT in patients with recurrent PC.
Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: results of a sequential PET/CT study in 22 patients / Schiavia R.; Vagnoni V.; Romagnoli D.; Pultrone C.; Rocca C.; Cividini R.; Bizzarri B.; Brunocilla E.; Manferrari F.; Garofalo M.; Martorana G.. - In: EUROPEAN UROLOGY. SUPPLEMENTS. - ISSN 1569-9056. - STAMPA. - 10:(2012), pp. 893-893. (Intervento presentato al convegno 27 EAU Congress tenutosi a Parigi nel 24-28 febbraio 2012) [10.1016/S1569-9056(12)60890-2].
Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: results of a sequential PET/CT study in 22 patients
SCHIAVINA, RICCARDO;VAGNONI, VALERIO;ROMAGNOLI, DANIELE;PULTRONE, CRISTIAN VINCENZO;CIVIDINI, RICCARDO;BRUNOCILLA, EUGENIO;MANFERRARI, FABIO;GAROFALO, MARCO;MARTORANA, GIUSEPPE
2012
Abstract
The influence of androgen deprivation therapy (ADT) on 11C-choline uptake in patients with recurrent prostate cancer (PC) has not yet been clarified and there are no recommendations in the literature about the question of whether ADT should be discontinued before 11C-choline PET/CT The aim of our study was to investigate this issue by means of sequential 11Ccholine positron emission tomography (PET)/CT in patients with recurrent PC.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
